Biomednewsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension For Compliance
(MENAFN- Investor Brand Network) CNS Pharmaceuticals (NASDAQ: CNSP) announced that it received an exception from the nasdaq Hearings Panel, granting the company until March 11, 2025, to meet the minimum bid price requirement under Nasdaq Listing Rule 5550( …